Product Description
Venipuncture is a medical procedure for piercing a vein for the purpose of intravenous or venous blood sampling. Venous puncture is the most common of all invasive medical procedures.
The Venipuncture, Phlebotomy and Overall Venous Access market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Venipuncture, Phlebotomy and Overall Venous Access market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Venipuncture, Phlebotomy and Overall Venous Access Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Venipuncture, Phlebotomy and Overall Venous Access market are:
Medtronic plc
AccuVein
BD
B. Braun Medical
MarketLab
NIPRO Medical Corp.
Heathrow Scientific
Kawasumi Laboratories America
Greatex Mills Inc.
Smiths Medical
Cardinal Health Inc.
Most important types of Venipuncture, Phlebotomy and Overall Venous Access products covered in this report are:
Cephalic Vein
Median Cubital Vein
Basilic Vein
Most widely used downstream fields of Venipuncture, Phlebotomy and Overall Venous Access market covered in this report are:
Hospitals
Diagnostic Labs
Physicians Offices
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.